Oncology professional societies criticised for financial links with industry

Extensive financial links between the leaders of US oncology professional associations and the pharmaceutical industry have raised concerns over independence and integrity. More than A$84 million (US$55.6m) in industry payments flowed to leaders of the American Society of Clinical Oncology (ASCO) over a five year period according to figures published in BMJ. Oncologists were ahead ...

Already a member?

Login to keep reading.

© 2021 the limbic